Einstein's institute for aging research: Collaborative and programmatic approaches in the search for successful aging

Experimental Gerontology

Volumn 39, Issue 2, 2004, Pages 151-157

  Barzilai, Nir ^a   Rossetti, Luciano ^a   Lipton, Richard B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Longevity; Traditional geriatic programs

Indexed keywords

AGING; CALORIC RESTRICTION; COGNITION; GERONTOLOGICAL RESEARCH; GERONTOLOGY; HUMAN; LONGEVITY; LONGITUDINAL STUDY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; REVIEW;

EID: 0842305086     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.10.009     Document Type: Article

References (29)

1. Atzmon G., Gabriely I., Greiner W., Davidson D., Barzilai N. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J. Gerontol. A Biol. Sci. Med. Sci. 57:2002;M712-M715.
2. Atzmon G., Schechter C., Greiner W., Davidson D., Rennert G., Barzilai N. Clinical phenotype of families with longevity. J. Am. Geriat. Soc. 2004;. (in press).
3. Barzilai N., Gupta G. Revisiting the role of fat mass in the life extension induced by caloric restriction. J. Gerontol. 54A:1999;B89-B96.
4. Barzilai N., Wang J., Massilon D., Vuguin P., Hawhins M., Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100:1997;3105-3110.
5. Barzilai N., Gabriely I., Gabriely M., Iankowitz N., Sorkin J.D. Offspring of centenarians have a favorable lipid profile. J. Am. Geriat. Soc. 49:2001;76-79.
6. Barzilai N., Atzmon G., Schechter C., Schaefer E., Cupples A.L., Lipton R.B., Cheng S., Shuldiner A.R. Unique lipoprotein phenotype and genotype in humans with exceptional longevity. J. Am. Med. Assoc. 290:2003;2030-2040.
7. Crystal M.A., Dickson D., Davies P., Masur D., Grober E., Lipton R.B. The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch. Neurol. 57:(5):2000;713-719.
8. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., Wu J., Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl Acad. Sci. USA. 24:(97):2000;12222-12226.
9. Gershon E.S. Making progress: does clinical research lead to breakthroughs in basic biomedical sciences? Perspect. Biol. Med. 42:1998;95-102.
10. Hartwell L. Bringing the basic scientist into human disease research. Mol. Biol. Cell. 3:1992;837-838.
11. Hamerman D., Zeleznik J. Translating basic aging research to geriatric health care. Exp. Gerontol. 36:2001;193-203.
12. Hansen B.C. The metabolic syndrome X. Ann. NY Acad. Sci. 892:1999;1-24.
13. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., Wiedmeyer H.M., Byrd-Holt D.D. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The third national health and nutrition examination survey, 1988-1994. Diab. Care. 21:(4):1998;518-524.
14. Gabriely I., Yang X.-M., Cases J.A., Ma X.-H., Rossetti L., Barzilai N. Glucose regulation of angiotensinogen gene expression. Am. J. Physiol. 281:2001;R795-R802.
15. Gabriely I., Yang X.-M., Cases J.A., Ma X.-H., Rossetti L., Barzilai N. Nutrient regulation of plasminoge activating inhibitor-1 gene expression. Artheriosclerosis. 160:2002;117-124.
16. Goldstein D.S. On the dialectic between molecular biology and integrative physiology: toward a new medical science. Perspect. Biol. Med. 40:1997;505-515.
17. Grober E., Lipton R.B., Hall C., Crystal H. Memory impairment on free and cued selective reminding predicts dementia. Neurology. 54:2000;827-832.
18. Hall C.B., Lipton R.B., Sliwinski M., Stewart W.F. A change point model for estimating the onset of cognitive decline in pre-clinical Alzheimer's disease. Stat. Med. 19:2000;1555-1566.
19. Hall C.B., Ying J., Kuo L., Sliwinski M., Buschke H., Katz M., Lipton R.B. Estimation of bivariate measurements having different change points, with application to cognitive ageing. Stat. Med. 20:2001;3695-3714.
20. Hall C.B., Ying J., Kuo L., Lipton R.B. Bayesian and profile likelihood change point methods for modeling cognitive function over time. Comput. Stat. Data Anal. 42:2003;91-109.
21. Hammes H.P., Du X., Edelstein D., Taguchi T., Matsumura T., Ju Q., Lin J., Bierhaus A., Nawroth P., Hannak D., Neumaier M., Bergfeld R., Giardino I., Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9:2003;294-299.
22. Lines C.R., McCarroll K.A., Lipton R.B., Block G.A. on behalf of the PRAISE study group. Telephone screening for amnestic mild cognitive impairmen. Neurology. 60:2003;261-266.
23. Lipton R.B., Katz M., Kuslansky G., Sliwinski M., Stewart W.F., Verghese J., Crystal H.A., Buschke H. Screening for dementia by telephone with the memory impairment screen. J. Am. Geriatric. Soc. 51:2003;1-9.
24. Manton K.G., Corder L.S., Stallard E. Monitoring changes in the health of the US elderly population: correlates with biomedical research and clinical innovations. Fed. Am. Soc. Exp. Biol. J. 11:1997;923-930.
25. Rossetti L. Perspective: hexosamines and nutrient sensing. Endocrinology. 141:(6):2000;1922-1925.
26. Rossetti L., Hawkins M., Chen W., Gindi J., Barzilai N. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J. Clin. Invest. 96:1995;132-140.
27. Verghese J., Lipton R.B., Hall C.B., Kuslansky G., Katz M.J., Buschke H. Related articles, links abstract abnormality of gait as a predictor of non-Alzheimer's dementia. N. Engl. J. Med. 347:(22):2002;1761-1768.
28. Verghese J., Lipton R.B., Katz M.J., Hall C.B., Derby C.A., Kuslansky G., Ambrose A.F., Sliwinski M., Buschke H. Related articles, links abstract leisure activities and the risk of dementia in the elderly. N. Engl. J. Med. 348:(25):2003;2508-2516.
29. Wang J., Liu R., Hawkins M., Barzilai N., Rossetti L. A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature. 393:1998;684-688.